Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
343 participants
OBSERVATIONAL
2019-05-16
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Survival in Patients Older Than 60 Years With Newly Diagnosed AML in Spain
NCT03435341
Treatment of Adult ALL With an MRD-directed Programme.
NCT00358072
Quality of Life and Care Organization of Patients With Chronic Myeloid Leukemia in the Lombardy Hematology Network
NCT07165535
Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy
NCT03096496
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
NCT06459024
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire
Health-related quality of life
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age at AML diagnosis ≥ 18 years,
* Date of AML diagnosis at least 5 years before study enrollment,
* AML-free status at study enrollment,
* Written informed consent provided.
Exclusion Criteria
* Not speaking and reading the language of the participating country,
* More than 75 years at the time of study enrollment,
* Receiving any active treatment for AML at the time of study enrollment.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Organisation for Research and Treatment of Cancer - EORTC
NETWORK
Gruppo Italiano Malattie EMatologiche dell'Adulto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fabio Efficace
Role: STUDY_CHAIR
GIMEMA Foundation
Frédéric Baron
Role: STUDY_DIRECTOR
European Organisation for Research and Treatment of Cancer - EORTC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UZ Gasthuisberg
Leuven, , Belgium
CHR Citadelle-CHU
Liège, , Belgium
University of Liège
Liège, , Belgium
KBC Rijeka
Rijeka, , Croatia
University Hospital Centre Zagreb
Zagreb, , Croatia
Les Hôpitaux Universitaires de Strasbourg
Lyon, , France
Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. LANCISI - G. SALESI
Ancona, , Italy
U.O. Ematologia con trapianto - Azienda Ospedaliero-Universitaria Policlinico di Bari
Bari, , Italy
UOC Ematologia Ospedale " Monsignor Raffaele Dimiccoli"
Barletta, , Italy
Divisione di Ematologia Ospedale A. Perrino
Brindisi, , Italy
ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO
Cagliari, , Italy
Divisione clinicizzata di Ematologia - Dipartimento di Scienze Mediche - Osp. Ferrarotto
Catania, , Italy
Azienda Ospedaliero Universitaria Arcispedale Sant'Anna Dipartimento di Scienze Mediche Sezione di Ematologia e Fisiopatologia dell'Emostasi
Cona, , Italy
Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria
Foggia, , Italy
IRCCS_AOU San Martino-IST.Clinica Ematologica
Genova, , Italy
Milano Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico UOC Oncoematologia- Padiglione Marcora 2° piano
Milan, , Italy
Azienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia
Napoli, , Italy
UOC di Ematologia-Centro Emofilia e Trombosi - Ospedale Ascalesi - ASL Napoli 1
Napoli, , Italy
S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro
Novara, , Italy
Orbassano Dip. di Scienze Cliniche e Biologiche - Ospedale S. Luigi Gonzaga-Medicina Interna 2
Orbassano, , Italy
Università degli Studi di Padova - Ematologia ed Immunologia Clinica
Padua, , Italy
U.O. di Ematologia con trapianto - A.U. Policlinico "Paolo Giaccone"
Palermo, , Italy
U.O. Ematologia e CTMO- AOU di Parma
Parma, , Italy
Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale G. da Saliceto
Piacenza, , Italy
Ematologia - Ospedale San Carlo
Potenza, , Italy
Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova
Reggio Emilia, , Italy
Az. Ospedaliera "Sant' Andrea"-Università la Sapienza Seconda Facoltà di Medicina e Chirurgia
Roma, , Italy
Divisione di Ematologia - Ospedale S.Eugenio
Roma, , Italy
Ematologia Policlinico - Università degli Studi di Roma Tor Vergata (PTV)
Roma, , Italy
Istituto di Semeiotica Medica - Ematologia - Università Cattolica del Sacro Cuore - Policlinico A. Gemelli
Roma, , Italy
Roma Divisione Ematologia - Università Campus Bio-Medico
Roma, , Italy
Università degli Studi "Sapienza" - Dip Medicina di Precisione e Ricerca Traslazionale UOC Ematologia
Roma, , Italy
U.O. di Ematologia - Casa Sollievo della Sofferenza
San Giovanni Rotondo, , Italy
Ematologia - AOU Sassari
Sassari, , Italy
Torino Dipartimento di Oncologia ed Ematologia S.C. Ematologia 2 A.O. Città della Salute e della Scienza di Torino San Giovanni Battista
Torino, , Italy
University Clinic of Hematology-Skopje
Skopje, , North Macedonia
University hospital Bratislava
Bratislava, , Slovakia
UKC Ljubljana
Ljubljana, , Slovenia
Ankara University School Of Medicine Cebeci Campus Adult Hematology Department and BMT Unit
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Johan Maertens
Role: primary
Aurélie Jaspers
Role: primary
Frédéric Baron
Role: primary
Duska Petranovic
Role: primary
Radovan Petranovic
Role: primary
Xavier Thomas
Role: primary
Attilio Olivieri
Role: primary
Francesco Albano
Role: primary
Giuseppe Tarantini
Role: primary
Domenico Pastore
Role: primary
Claudio Romani
Role: primary
Francesco Di Raimondo
Role: primary
Maria Ciccone
Role: primary
Silvana Franca Capalbo
Role: primary
Roberto Massimo Lemoli
Role: primary
Nicola Fracchiolla
Role: primary
Fabrizio Pane
Role: primary
Angiolina Rocino
Role: primary
Monia Lunghi
Role: primary
Daniela Cilloni
Role: primary
Carmela Gurrieri
Role: primary
Maria Enza Mitra
Role: primary
Monica Cugnola
Role: primary
Daniele Vallisa
Role: primary
Nunzio Filardi
Role: primary
Imovilli Annalisa
Role: primary
Agostino Tafuri
Role: primary
Paolo De Fabritiis
Role: primary
Luca Maurillo
Role: primary
Simona Sica
Role: primary
Giuseppe Avvisati
Role: primary
Maurizio Martelli
Role: primary
Nicola Cascavilla
Role: primary
Claudio Fozza
Role: primary
Ernesta Audisio
Role: primary
Irina Panovska
Role: primary
Martin Mistrik
Role: primary
Matevz Skerget
Role: primary
Maltem Yuksel
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GIMEMA-EORTC 1621-QLG-LG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.